April 20, 2021
Critical Care SmartBrief
Critical Care Update
University of Pittsburgh Medical Center data showed risk-adjusted mortality, successful discharge and ICU admissions were only slightly different after adhering to the federally required SEP-1 treatment protocol for sepsis, compared with what would have been expected without the mandate. The study, reported in the Annals of Internal Medicine, found that throughout the 11-hospital system, ICU admission was 22.4% after the protocols were implemented, compared with a 20.4% expected rate.
Full Story: MedPage Today (free registration) (4/19) 
LinkedIn Twitter Facebook Email
The number of new COVID-19 cases in the US fell by 0.4% for the week ending April 18, following four consecutive weeks of increase, but the country still logged almost 70,000 new cases per day last week as variants continue to spread. The average number of patients hospitalized with COVID-19 climbed by 5% to over 41,000, marking the third straight weeks of increase, while related fatalities dropped 2.8%.
Full Story: Reuters (4/19) 
LinkedIn Twitter Facebook Email
Shifting wound care experience during COVID-19
For most patients, wound care is a very personal and novel experience and a patient's connection to their doctor as their wound is treated is sometimes as important as the treatment itself. Patients have questions and concerns that need a personal touch as they engage in their healing journey. Care for wound patients rapidly shifted in the spring of 2020. Enter the 3M home support.
Critical Care Survey
View the results of last week's survey question on experiences with non-ICU staff.

New survey: Describe a successful aspect or instance of teamwork you've witnessed amid the COVID-19 pandemic.

Take the survey and share your thoughts. Responses will be shared in next week's Critical Care SmartBrief.
LinkedIn Twitter Facebook Email
Medicine in the News
The CDC could decide by Friday if restrictions will be added to the Johnson & Johnson vaccine after six women reported blood clotting issues after receiving the shot, according to National Institute of Allergy and Infectious Diseases Director Anthony Fauci. The US paused use of J&J's vaccines last week.
Full Story: KOMO-TV/KOMO-AM (Seattle) (4/19) 
LinkedIn Twitter Facebook Email
CDC: Americans 16 and up can now get COVID-19 vaccine
(Joe Raedle/Getty Images)
All US individuals ages 16 and older can now receive a COVID-19 vaccine, according to the CDC, which said those with underlying medical conditions that raise the risk for serious complications should be given priority. Nearly 211.6 million COVID-19 vaccine doses had been administered in the US as of Monday, with more than 85.3 million people now fully vaccinated.
Full Story: Reuters (4/19),  Reuters (4/20) 
LinkedIn Twitter Facebook Email
Free eBooks and Resources
Free eBooks and resources brought to you by our partners
Trends and Technology
The US will allocate $1.7 billion to facilitate detection, monitoring and mitigation of emerging and potentially more infectious coronavirus variants, according to the Biden administration. About half of current US cases involve variant forms of the virus, a figure that "underscores the critical need for rapid and ongoing genomic surveillance," said CDC Director Rochelle Walensky.
Full Story: CNBC (4/16) 
LinkedIn Twitter Facebook Email
A skin sweat sensor that can continuously measure cytokine levels for approximately 168 hours has been developed by researchers from Texas startup EnLiSense and the University of Texas. The device has been modified and can be used to monitor COVID-19 patients.
Full Story: MedGadget (4/16) 
LinkedIn Twitter Facebook Email
Sharing Critical Care SmartBrief with your network keeps the quality of content high and these newsletters free.
Help Spread the Word
Or copy and share your personalized link:
April prepares her green traffic light and the world thinks Go.
Christopher Morley,
writer, editor, journalist
LinkedIn Twitter Facebook Email
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004